UAE to start manufacturing the Sinopharm vaccine

An experimental coronavirus vaccine developed by Chinese state-owned pharmaceutical giant Sinopharm has 86% efficacy was based on an interim analysis of the late-stage clinical trials which the UAE started in July and now the United Arab Emirates will start manufacturing the Chinese drugmaker the Sinopharm vaccine

The local production plan will cater to local and global demand and will complement the millions of shots already received to inoculate its people.

A probe into if the vaccine is suitable for children, a further study of new strains and the ability of the incumbent vaccine to fight them, and a campaign to ensure volunteers who received a placebo during Phase III Trials receive the vaccination, are among major developments expected in coming months